Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07111663 · ClinicalTrials.gov registry record
An Observational Study of Individuals With Isolated Dystonia
A clinical trial of Isolated/Primary Dystonia That Affects More Than One Region of the Body, sponsored by Vima Therapeutics.
- Recruiting
- Registry status
- 200
- Enrollment target
- 20
- Study locations
NCT07111663: Recruiting study of Isolated/Primary Dystonia That Affects More Than One Region of the Body, sponsored by Vima Therapeutics.
NCT07111663 is a study of Isolated/Primary Dystonia That Affects More Than One Region of the Body that is actively recruiting participants, run by Vima Therapeutics. The registered enrollment target is 200 participants. The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07111663, a study of Isolated/Primary Dystonia That Affects More Than One Region of the Body, is actively recruiting participants, sponsored by Vima Therapeutics.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is an observational study in individuals with isolated (or primary) dystonia that involves more than one body region. The purpose of the study is to collect detailed information to help your physician and other researchers understand how dystonia impacts your and other patients' lives and how the disease changes over time. The study may also help researchers better understand the clinical scales that are commonly used to evaluate dystonia symptoms and how they affect various areas of life such as well-being, pain, relationships and social interactions, and progress over time. Because this is an observational study, you will not receive any interventional treatment in the study.
Primary Outcome
The BFM was developed to quantitatively assess primary dystonias (Burke 1985). It is composed of 2 subscales: a movement subscale, based on the clinician's evaluation of the patient in nine body areas, and a disability subscale, based on the participant's report of disability in activities of daily living.
Conditions Studied
Study Locations (20)
Florida
- Vima Site #003 - Boca Raton
- Vima Site #009 - Gainesville
- Vima Site #008 - Miami
- Vima Site #031 - Orlando
California
- Vima Site #010 - Aliso Viejo
- Vima Site #030 - Los Angeles
- Vima Site #022 - Palo Alto
New York
- Vima Site #017 - Commack
- Vima Site #018 - New York
- Vima Site #024 - New York
Arizona
- Vima Site #004 - Scottsdale
- Vima Site #028 - Sun City
Colorado
- Vima Site #019 - Englewood
Georgia
- Vima Site #005 - Atlanta
Illinois
- Vima Site #027 - Chicago
Maryland
- Vima Site #007 - Olney
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-06-17 |
| Est. Completion | 2026-10 |
What NCT07111663 shows while recruiting
NCT07111663 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Isolated/Primary Dystonia That Affects More Than One Region of the Body appearing as the primary indexed condition, and to 0 interventions.
NCT07111663 names 20 study sites across 12 states, led by Florida, California, New York.
Frequently Asked Questions
What is clinical trial NCT07111663 about?
NCT07111663 is a clinical study titled "An Observational Study of Individuals With Isolated Dystonia". This is an observational study in individuals with isolated (or primary) dystonia that involves more than one body region. The purpose of the study is to collect detailed information to help your physician and other researchers understand how dystonia impacts your and other patients' lives and how t...
What is the current status of trial NCT07111663?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-06-17. Estimated completion is 2026-10.
What conditions does trial NCT07111663 study?
This clinical trial studies the following conditions: Isolated/Primary Dystonia That Affects More Than One Region of the Body.
Who is sponsoring clinical trial NCT07111663?
This trial is sponsored by Vima Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07111663 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI